Clinical Trials on Glabellar Crease in Australia
Total 612 results
-
Eli Lilly and CompanyNSABP Foundation IncActive, not recruitingBreast CancerUnited States, Spain, China, France, Canada, Taiwan, United Kingdom, Singapore, Australia, Italy, Japan, Hungary, India, Belgium, Germany, New Zealand, Saudi Arabia, Brazil, Finland, Austria, Mexico, Greece, Czechia, Portugal, Argentina, ... and more
-
PfizerRecruitingBreast CancerChina, Australia, United States, Japan, Spain, Hungary, France, Canada, Taiwan, Germany, Slovakia, Belgium, Czechia, Finland, India, Italy, United Kingdom, Sweden, Bulgaria, Greece, Mexico, Brazil, Israel, Turkey (Türkiye), South Korea, P... and more
-
Hoffmann-La RocheActive, not recruitingBreast CancerHungary, Spain, Taiwan, United States, Australia, United Kingdom, China, France, Greece, Thailand, India, Germany, Denmark, Belgium, Bulgaria, Ukraine, Hong Kong, New Zealand, Poland, Czechia, Brazil, Romania, Portugal, Italy, Austria, Me... and more
-
Novartis PharmaceuticalsCompletedBreast CancerChina, United States, France, Italy, United Kingdom, Taiwan, Turkey, Egypt, Germany, Hong Kong, Belgium, Canada, Russian Federation, Lebanon, Japan, Australia, Greece, Korea, Republic of, Ireland, Peru, Argentina, Brazil, Colombia, South... and more
-
Hoffmann-La RocheCompletedBreast CancerIsrael, Italy, Poland, Spain, China, Hong Kong, Australia, Canada, Sweden, Switzerland, United States, South Africa, United Kingdom, Germany, Portugal, Taiwan, Japan, Russian Federation, Singapore, France, Netherlands, Belgium, Austria and more
-
Eli Lilly and CompanyCompletedMelanoma | Breast Cancer | Non-small Cell Lung Cancer | Brain MetastasesSpain, United States, Australia, Italy, France, Belgium, Canada, Austria, Israel
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerUnited States, China, Germany, Canada, Malaysia, Taiwan, France, Japan, Thailand, Italy, Australia, Argentina, Brazil, India, Poland, Spain, Sweden, United Kingdom, Vietnam, Belgium, Denmark, South Korea, Turkey (Türkiye)
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Moyamoya Disease | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar... and other conditionsUnited States, Australia
-
AstraZenecaActive, not recruitingLocally Advanced (Inoperable) or Metastatic Breast CancerUnited States, Italy, Spain, Belgium, Hungary, Canada, France, Germany, Japan, Peru, Poland, United Kingdom, China, Taiwan, Israel, Australia, Argentina, South Korea, Russia
-
AmgenDaiichi Sankyo, Inc.TerminatedBreast CancerUnited States, Denmark, France, Italy, Belgium, Canada, Czechia, Germany, Netherlands, United Kingdom, Korea, Republic of, Peru, Philippines, Poland, Russian Federation, Taiwan, Spain, Australia, Hong Kong, Slovakia, Israel, Hungary, Portug... and more
-
Daiichi SankyoAstraZeneca; NSABP Foundation Inc; Spanish Breast Cancer Research Group (SOLTI); GBG Forschungs GmbHActive, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Brazil, United Kingdom, Denmark, Israel, Belgium, Japan, Taiwan, Chile, Peru, China, Canada, Italy, Ireland, Poland, Australia, Portugal, Greece, Czechia, Singapore, Mexico, Romania, Argentina, Hong Kong, Netherlan... and more
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Krebsforschung Schweiz, Bern, Switzerland; Rising Tide FoundationRecruitingLymphedema, Breast CancerUnited States, Switzerland, Spain, Germany, Brazil, Romania, Sweden, Canada, Israel, Taiwan, Austria, Belgium, Greece, Italy, Netherlands
-
Celcuity IncActive, not recruitingBreast CancerUnited States, Taiwan, France, United Kingdom, Belgium, Spain, Singapore, Greece, India, Australia, Germany, Canada, Italy, Romania, Argentina, Czechia, South Korea, Austria, Brazil, Bulgaria, Hungary, Mexico, Poland
-
University Hospital, Basel, SwitzerlandMemorial Sloan Kettering Cancer CenterActive, not recruitingBreast CancerUnited States, Korea, Republic of, Slovenia, Latvia, Turkey, Israel, Switzerland, Germany, Spain, Greece, Norway, Russian Federation, Lithuania, Austria, Netherlands, Croatia, Brazil, Canada, Portugal, Italy, Argentina, Chile, Egypt, ... and more
-
AstraZenecaTerminatedBreast CancerUnited States, Italy, Spain, Canada, Switzerland, United Kingdom, Israel, Brazil, Austria
-
Hoffmann-La RocheCompletedBreast CancerSpain, United Kingdom, Belgium, Austria, Brazil, France, Germany, Hungary, Italy, Thailand, Korea, Republic of, Hong Kong, Romania, Canada, Argentina, Czechia, Peru, Estonia, Mexico, Poland, Russian Federation, Croatia, Netherlands
-
Hoffmann-La RocheCompletedBreast CancerItaly, Austria, Belgium, Germany, Spain, United Kingdom, Hungary, Poland, Sweden
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Bulgaria, Spain, Poland, Finland, United Kingdom, Austria, Italy, Greece, Czech Republic, Croatia
-
PfizerCompletedBreast NeoplasmsUnited States, Canada, Spain, United Kingdom, Australia, Belgium, Korea, Republic of, Japan, Czechia, France, Germany, Hungary, Ireland, Italy, Poland, Russian Federation, Taiwan, Ukraine
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast CancerBelgium, Denmark, Finland, Italy, Spain, Sweden, United States, Canada, Germany, Japan, Netherlands, Portugal, Poland, Switzerland, Australia, Norway, United Kingdom, Ireland
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AG; AstraZenecaCompletedHematologic Neoplasms | Cancer Head Neck | Cancer, Breast | Cancer of Stomach | Cancer of Unknown Origin | Cancer Colorectal | Cancer, Lung | Cancer of Skin | Cancer of Esophagus | Cancer Refractory | Cancer, Bladder | Cancer, Uterus | Cancer Cervix | Cancer Liver | Cancer, KidneyAustria
-
Hoffmann-La RocheCompletedBreast CancerIsrael, Spain, France, Greece, Germany, Austria, Italy, Hungary, Croatia, Argentina, Brazil, Slovakia, Switzerland
-
Hoffmann-La RocheCompletedBreast NeoplasmsHungary, Italy, United Kingdom, Canada, Czechia, Bulgaria, Croatia, Dominican Republic, France, Germany, Greece, Guatemala, Hong Kong, Indonesia, Ireland, Korea, Republic of, Netherlands, Panama, Peru, Poland, Portugal, Slovakia, Spain and more
-
ExelixisCompletedCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Australia, Belgium, France, Italy, Korea, Republic of, Netherlands, Spain, United Kingdom
-
PfizerActive, not recruitingAdvanced or Metastatic Breast CancerUnited States, China, Canada, Taiwan, Japan, India, Argentina, Brazil, Australia, United Kingdom, Mexico, South Korea, Turkey (Türkiye), Israel
-
AstraZenecaMerck Sharp & Dohme LLC; NRG Oncology; Breast International Group; Myriad Genetic... and other collaboratorsActive, not recruitingBreast CancerUnited States, Belgium, Italy, Spain, United Kingdom, France, Switzerland, Canada, Germany, Netherlands, Japan, Poland, China, Austria, Taiwan, Australia, Argentina, Israel, Hungary, Portugal, Sweden, Iceland, Puerto Rico, South Korea
-
Eli Lilly and CompanyCompletedBreast CancerUnited States, Canada, Australia, Belgium, Brazil, Croatia, Czechia, Egypt, Germany, Ireland, Israel, Korea, Republic of, Lebanon, New Zealand, Peru, Poland, Russian Federation, Serbia, Slovakia, South Africa, Spain, Taiwan, United...
-
Novartis PharmaceuticalsCompletedBreast NeoplasmsUnited States, France, Spain, United Kingdom, Croatia, Turkey, Netherlands, Argentina, Australia, Canada, Czechia, Germany, Italy, Poland, Russian Federation, Brazil, Bulgaria, Chile, Denmark, Hungary, Ireland, Peru, South Africa, Col... and more
-
GlaxoSmithKlineActive, not recruitingNeoplasmsUnited States, Australia, Spain, Canada, China, Japan, United Kingdom, France, South Korea
-
Hoffmann-La RocheCompletedBreast NeoplasmsItaly, Netherlands, Belgium, United Kingdom, Argentina, Austria, Brazil, China, Ecuador, Estonia, Finland, France, Germany, Greece, Mexico, Peru, Poland, Portugal, Slovenia, Spain, United Arab Emirates, Canada, Hungary, Israel, Sweden, Tu... and more
-
Merck Sharp & Dohme LLCActive, not recruitingBreast CancerUnited States, Australia, Belgium, Brazil, Canada, China, Colombia, Costa Rica, France, Germany, Hungary, Ireland, Israel, Japan, Korea, Republic of, New Zealand, Poland, Portugal, Puerto Rico, Russian Federation, Spain, Taiwan, Ukr... and more
-
Hoffmann-La RocheCompletedBreast CancerAustralia, France, Germany, Israel, Italy, Spain, Sweden, China, Hong Kong, Canada, Switzerland, Portugal, Russian Federation, Czech Republic, Brazil, Austria, Estonia, Slovakia, Netherlands, Bulgaria, Hungary, Latvia, Mexico, Slovenia, United Kingdom and more
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Japan, South Korea
-
Celcuity IncRecruitingBreast CancerUnited States, Belgium, Spain, Italy, France, Malaysia, Australia, Argentina, Greece, Thailand, Czechia, Bulgaria, Brazil, Mexico, Germany, Hungary, Poland, Portugal, Romania, Taiwan, South Korea, Turkey (Türkiye)
-
Novartis PharmaceuticalsNational Cancer Institute (NCI); Canadian Cancer Trials Group; North Central... and other collaboratorsCompletedNeoplasms, BreastChina, Germany, United States, Belgium, Spain, Estonia, India, United Kingdom, Austria, France, Argentina, Australia, Czechia, Denmark, Greece, Israel, Japan, Netherlands, Norway, Poland, Russian Federation, Switzerland, Taiwan, Korea... and more
-
PfizerInternational Collaborative Cancer GroupCompletedBreast NeoplasmsAustralia, Denmark, Netherlands, United States, Bulgaria, Hungary, Italy, Spain, Belgium, Czech Republic, Ireland, Poland, Russian Federation, Sweden, United Kingdom, Croatia, Serbia, Germany, Bosnia and Herzegovina, Norway, South... and more
-
BayerTerminatedBreast NeoplasmsSpain, Canada, United States, Finland, Austria, Singapore, Czechia, Israel, Korea, Republic of, Netherlands, Taiwan, United Kingdom, Poland, Germany, Hong Kong, Denmark, Switzerland, Ireland, France, Norway
-
Pierre Fabre Pharma GmbHWinicker Norimed GmbHCompletedBreast Cancer | Non-Small-Cell Lung CancerGermany, Austria
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingHER2-positive Breast Cancer | HER2-positive Biliary Tract Cancer | HER2-Positive Salivary Gland Carcinomas | HER2-Positive Advanced Solid TumorChina, Australia, United States
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerBelgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Hungary, Japan, Mexico, China, Malaysia, Spain, Austria, Portugal, Poland, Norway, Bulgaria, Slovakia, Czechia, Chile, Switzerland, South Korea, Russia, Turkey...
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, Italy, Spain, United Kingdom, Austria, Czechia, Hungary, Malaysia, Saudi Arabia, Taiwan, Argentina, France, Israel, Netherlands, Russian Federation, Hong Kong, Thailand, Lebanon, Bulgaria, Denmark, Po... and more
-
UMC UtrechtM.D. Anderson Cancer Center; Odense University Hospital; Radboud University Medical... and other collaboratorsRecruitingNeoplasms | Quality of Life | Breast Cancer | Head and Neck Cancer | Head and Neck Neoplasms | Gynecologic Cancer | Liver Neoplasms | Pancreatic Neoplasms | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Rectal Cancer | Rectal Neoplasms | Prostate Cancer | Brain Cancer | Brain Tumor | Bladder Cancer | Liver Metastases | T... and other conditionsUnited States, Netherlands, Germany, Canada, Denmark, United Kingdom, Australia, Italy, Belgium
-
Novartis PharmaceuticalsRecruiting
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerUnited States, China, Australia, Poland, Spain, United Kingdom, Canada, Italy, Mexico, Vietnam, France, Japan, Taiwan, Thailand, Hong Kong, Brazil, India, Philippines, South Africa, Singapore, Germany, Argentina, South Korea, Turkey (Türkiye)
-
PfizerActive, not recruitingBreast NeoplasmsAustria, Germany
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationKorea, Republic of, United States, Australia, Spain, Belgium, France, Ireland, Taiwan, Poland, Germany, Israel, Brazil, United Kingdom, Italy, Russian Federation, Ukraine
-
PfizerCompletedBreast NeoplasmsNetherlands, Canada, United States, Greece, Austria, Czech Republic, Ireland, Italy, Poland, Romania, Russian Federation, Spain, United Kingdom, Belgium, Germany, Denmark, France, Norway
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingUterine Cervical Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Triple Negative Breast Neoplasms | Pancreatic NeoplasmSpain, Japan, France, United States, Italy, Australia, South Korea